To determine the potential of baseline CSF GFAP levels to serve as a predictor of cognitive transition (from NC to MCI or dementia, or from MCI to dementia) in patients with newly diagnosed PD over an 8-year follow-up period, we performed Kaplan–Meier survival curves and Cox regression analysis. This evidence concerns the gene GFAP and dementia.